Tag: regdanvimab
Celltrion announces positive top-line results from global Phase III trial of regdanvimab (CT-P59)
Celltrion Group today announced top-line efficacy and safety data from the global Phase III clinical trial, demonstrating that anti-COVID-19 monoclona [...]
1 / 1 POSTS